PCDGF RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

Title:

PCDGF RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

Document Type and Number:

WIPO Patent Application WO2005000207

Kind Code:

A3

Abstract:

The present invention relates to the use of antitumor compositions capable of inhibiting PCDGF biological activity for the treatment of cancers. In particular the present invention relates to the use of PCDGF antagonist, e.g., antibodies that prevent PCDGF from binding its receptor, Rse (also referred to as "Sky" and "Tyro3").

Inventors:

KIENER PETER (US)
LANGERMANN SOLOMON (US)
KINCH MICHAEL (US)
BRUCKHEIMER ELIZABETH M (US)

Application Number:

PCT/US2004/016547

Publication Date:

May 26, 2005

Filing Date:

May 26, 2004

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MEDIMMUNE INC (US)
KIENER PETER (US)
LANGERMANN SOLOMON (US)
KINCH MICHAEL (US)
BRUCKHEIMER ELIZABETH M (US)

International Classes:

A61K39/395; C07K16/28; C07K16/30; C12P21/04; A61K; (IPC1-7): A61K39/395; C07K16/30; C12P21/04

Foreign References:

US20030099646A1

2003-05-29

Download PDF:

View/Download PDF PDF Help

Previous Patent: SYSTEM AND METHOD FOR DETECTING, DIAGNOSING, AND TREATING CARDIOVASCULAR DISEASE

Next Patent: COMBINATION THERAPY FOR THE TREATMENT OF NEOPLASMS